These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7994046

  • 1. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
    Clark SS, Liang Y, Reedstrom CK, Wu SQ.
    Blood; 1994 Dec 15; 84(12):4301-9. PubMed ID: 7994046
    [Abstract] [Full Text] [Related]

  • 2. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.
    Whitlock CA, Ziegler SF, Witte ON.
    Mol Cell Biol; 1983 Apr 15; 3(4):596-604. PubMed ID: 6304498
    [Abstract] [Full Text] [Related]

  • 3. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S, Vigon I, Dusanter I, Charon M, Velu T, Baillou C, Gisselbrecht S, Lemoine FM.
    J Immunol; 1995 Feb 15; 154(4):1577-86. PubMed ID: 7836743
    [Abstract] [Full Text] [Related]

  • 4. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.
    Whitlock CA, Witte ON.
    J Virol; 1981 Nov 15; 40(2):577-84. PubMed ID: 6275106
    [Abstract] [Full Text] [Related]

  • 5. Increased detection of specific tyrosine phosphoproteins correlates with tumor progression of Abelson virus-infected lymphocytes.
    Clark SS, Liang Y.
    Leukemia; 1995 Jan 15; 9(1):165-74. PubMed ID: 7845013
    [Abstract] [Full Text] [Related]

  • 6. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
    Thome KC, Radfar A, Rosenberg N.
    J Virol; 1997 Nov 15; 71(11):8149-56. PubMed ID: 9343165
    [Abstract] [Full Text] [Related]

  • 7. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
    Weissinger EM, Mischak H, Goodnight J, Davidson WF, Mushinski JF.
    Mol Cell Biol; 1993 Apr 15; 13(4):2578-85. PubMed ID: 8455630
    [Abstract] [Full Text] [Related]

  • 8. Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.
    Poirier Y, Kozak C, Jolicoeur P.
    J Virol; 1988 Nov 15; 62(11):3985-92. PubMed ID: 2845118
    [Abstract] [Full Text] [Related]

  • 9. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D, Griffin DS, Mainville C, Rosenberg N.
    J Virol; 2003 Apr 15; 77(8):4617-25. PubMed ID: 12663768
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus.
    Noronha EJ, Sterling KH, Calame KL.
    J Biol Chem; 2003 Dec 19; 278(51):50915-22. PubMed ID: 14559912
    [Abstract] [Full Text] [Related]

  • 11. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
    Green PL, Kaehler DA, Risser R.
    J Virol; 1987 Jul 19; 61(7):2192-7. PubMed ID: 3035219
    [Abstract] [Full Text] [Related]

  • 12. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.
    Young JC, Gishizky ML, Witte ON.
    Mol Cell Biol; 1991 Feb 19; 11(2):854-63. PubMed ID: 1990288
    [Abstract] [Full Text] [Related]

  • 13. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.
    Clark SS, Chen E, Fizzotti M, Witte ON, Malkovska V.
    J Virol; 1993 Oct 19; 67(10):6033-46. PubMed ID: 8396667
    [Abstract] [Full Text] [Related]

  • 14. v-abl causes hematopoietic disease distinct from that caused by bcr-abl.
    Scott ML, Van Etten RA, Daley GQ, Baltimore D.
    Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6506-10. PubMed ID: 1862078
    [Abstract] [Full Text] [Related]

  • 15. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
    Jacobsen EA, Ananieva O, Brown ML, Chang Y.
    J Immunol; 2006 Jun 01; 176(11):6831-8. PubMed ID: 16709843
    [Abstract] [Full Text] [Related]

  • 16. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.
    Rosenberg NE, Clark DR, Witte ON.
    J Virol; 1980 Dec 01; 36(3):766-74. PubMed ID: 6257926
    [Abstract] [Full Text] [Related]

  • 17. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA, Parmar K, Unnikrishnan I, Gong L, Raffel GD, Rosenberg N.
    J Virol; 2001 Feb 01; 75(4):1816-23. PubMed ID: 11160680
    [Abstract] [Full Text] [Related]

  • 18. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
    Sugiyama H, Wang Y, Jackson P, Sawyers CL, Klein G.
    Int J Cancer; 1994 Jul 01; 58(1):135-41. PubMed ID: 8014009
    [Abstract] [Full Text] [Related]

  • 19. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD, Henkemeyer MJ, Kaehler DA, Hoffmann FM, Risser R.
    J Virol; 1990 May 01; 64(5):2226-35. PubMed ID: 2157882
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.